Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Galantamine in Tic Disorders
NCT00226824Phase 4Terminated
- Start
- Sep 2005
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of galantamine in Tourette syndrome (TS), chronic motor tic disorder, persistent vocal tic disorder. Started Sep 2005; status: terminated.
02
Drugs
galantamine
03
Conditions
Tourette syndrome (TS)chronic motor tic disorderpersistent vocal tic disorder
Beyond the preview
Go deeper on NCT00226824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00226824.